China Meheco Group Co., Ltd. (SHA:600056)

China · Delayed Price · Currency is CNY

10.40

+0.12 (1.17%)

Apr 29, 2026, 11:29 AM CST

3.28% (1Y)

Market Cap	15.38B
Revenue (ttm)	35.36B
Net Income (ttm)	473.23M
Shares Out	1.50B
EPS (ttm)	0.32
PE Ratio	32.49
Forward PE	n/a
Dividend	0.11 (1.03%)
Ex-Dividend Date	n/a

Volume	8,217,810
Average Volume	47,553,419
Open	10.28
Previous Close	10.28
Day's Range	10.28 - 10.42
52-Week Range	9.75 - 12.48
Beta	0.23
RSI	45.07
Earnings Date	Apr 25, 2026

About China Meheco Group

China Meheco Group Co., Ltd. engages in the manufacture, marketing, and trade of pharmaceuticals and medical devices in China and internationally. The company is involved in the planting and sale of Chinese medicinal materials, as well as the provision of related technical and warehousing services. Its drug products cover therapeutic fields, such as anti-infection, cardiovascular, hormones and endocrine regulation, respiratory and digestive systems, nutritional supplements, antipyretic analgesics, and other therapeutic areas as well as Chinese ... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 1983

Employees 8,368

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600056

Full Company Profile

Financial Performance

In 2025, China Meheco Group's revenue was 35.36 billion, an increase of 3.55% compared to the previous year's 34.15 billion. Earnings were 473.23 million, a decrease of -11.62%.

Financial Statements

News

There is no news available yet.